Jacques De Grève
Impact in
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 0.5%
- PARP inhibition in cancer therapy
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
Papers in
- Oncology 108
- Colorectal Cancer Treatments and Studies 27
- HER2/EGFR in Cancer Research 16
- PARP inhibition in cancer therapy 16
- Cancer Treatment and Pharmacology 15
- Lung Cancer Research Studies 10
-
- RNA Interference and Gene Delivery 9
- Co-authors
- Erik Teugels (60 shared papers)Lore Decoster (49 shared papers)Ijeoma Adaku Umelo (14 shared papers)Denis Schallier (31 shared papers)Armando Santoro (4 shared papers)Arié Figer (4 shared papers)M. Moscovici (4 shared papers)Chetan Lathia (3 shared papers)
- Journals
- Journal of Clinical Oncology (39 papers)Annals of Oncology (16 papers)European Journal of Cancer (9 papers)Oncotarget (6 papers)Journal of Thoracic Oncology (6 papers)
- Partner nations
- BelgiumUnited StatesNetherlands
In The Last Decade
Jacques De Grève
249 papers receiving 8.1k citations
Jacques De Grève's Hit Papers
Peers
Comparison fields: 5 of 143
- Hepatology 832
- Oncology 2.8k
- Geriatrics and Gerontology 309
- Cancer Research 987
- Genetics 464
Countries citing papers authored by Jacques De Grève
This map shows the geographic impact of Jacques De Grève's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques De Grève with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques De Grève more than expected).
Fields of papers citing papers by Jacques De Grève
This network shows the impact of papers produced by Jacques De Grève. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques De Grève. The network helps show where Jacques De Grève may publish in the future.
Co-authors
The 25 scholars most cited alongside Jacques De Grève, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 259 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase II Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma Hit paper breakdown → | 2006 | 951 |
| 2 | Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses in BRCA Carrier Ovarian Cancer Correlating With Platinum-Free Interval Hit paper breakdown → | 2010 | 753 |
| 3 | Phase I Study of 68Ga-HER2-Nanobody for PET/CT Assessment of HER2 Expression in Breast Carcinoma Hit paper breakdown → | 2015 | 350 |
| 4 | 2013 | 259 | |
| 5 | 2013 | 239 | |
| 6 | 2012 | 216 | |
| 7 | 2009 | 183 | |
| 8 | 2001 | 146 | |
| 9 | 1988 | 137 | |
| 10 | 2004 | 128 | |
| 11 | 2007 | 128 | |
| 12 | 2007 | 122 | |
| 13 | 2010 | 115 | |
| 14 | 2012 | 112 | |
| 15 | 1998 | 103 | |
| 16 | 2017 | 99 | |
| 17 | 1988 | 98 | |
| 18 | 2010 | 96 | |
| 19 | Safety and Efficacy of Sorafenib in Patients with Hepatocellular Carcinoma (HCC) and Child-Pugh A versus B Cirrhosis. | 2011 | 79 |
| 20 | 2017 | 75 |
About Jacques De Grève
Jacques De Grève is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Genetics and Cancer Research, having authored 259 papers that have together received 8.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (35 papers), Colorectal Cancer Treatments and Studies (27 papers), BRCA gene mutations in cancer (26 papers), HER2/EGFR in Cancer Research (16 papers), PARP inhibition in cancer therapy (16 papers), Cancer Treatment and Pharmacology (15 papers), Lung Cancer Research Studies (10 papers) and RNA Interference and Gene Delivery (9 papers). The work is most often cited by research in Hepatology (832 citations), Oncology (2.8k citations), Geriatrics and Gerontology (309 citations), Cancer Research (987 citations) and Genetics (464 citations). Jacques De Grève has collaborated with scholars based in Belgium, United States and Netherlands. Frequent co-authors include Erik Teugels, Lore Decoster, Ijeoma Adaku Umelo, Denis Schallier, Armando Santoro, Arié Figer, M. Moscovici, Chetan Lathia, Christel Fontaine and Peter Kronenberger. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, Oncotarget and Journal of Thoracic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.